GF
INSM icon

Gabelli Funds’s Insmed INSM Stock Holding History

Gabelli Funds’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912K Buy
8,550
+5,850
+217% +$708K 0.01% 951
2026
Q1 		$442K Buy
2,700
+860
+47% +$132K ﹤0.01% 1057
2025
Q4 		$320K Buy
1,840
+400
+28% +$73K ﹤0.01% 1105
2025
Q3 		$207K Buy
+1,440
New +$176K ﹤0.01% 1152

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Gabelli Funds's INSM Position: Q2 2026 in Review

Gabelli Funds increased its Insmed (INSM) stake by 217% in Q2 2026, buying an estimated $708K and bringing the position to 8,550 shares worth $912K. The position accounts for 0.01% of the portfolio, ranked #951.

Gabelli Funds first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Gabelli Funds held 8,550 shares of Insmed worth $912K as of Q2 2026.
  • Gabelli Funds bought 5,850 Insmed shares in Q2 2026, an estimated $708K.
  • Insmed made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #951 holding.
  • Gabelli Funds first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.